Alfuzosin: A Comprehensive Study Report on Its Pharmacology, Therapeutic Uses, and Clinical Profile
-
BY Clemmie Chubb
- July 21, 2026 3:43 pm
- no comment
Alfuzosin is a selective alpha-1 adrenergic receptor antagonist primarily used in the management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Since its introduction, it has established itself as a cornerstone in urological therapeutics, offering symptomatic relief by relaxing smooth muscle in the prostate and bladder neck. This report provides a […]